Patanjali Foods Ltd Q2 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/6hs4gm3fb9qh79rpxx2r1vbk.pdf

Key Takeaways


The Edible Oil Shock: What Happened and What's Left

Asthana: "It was a perfect storm why the prices from where they went suddenly they collapsed."

Food Business Integration: A Windfall Quarter, Not a Run Rate

Asthana: "Overall margin of 25.9% or thereabout that we have on the food business will this be sustained probably the answer is that it will be to huge challenge to maintain this kind of momentum."

Nutraceuticals: A Bumper Quarter With a Sustainability Question


Edible Oil: The Case for Keeping It

Asthana: "If we can rotate this capital even six times a year and we make on an average let us say 4% margin you are talking about 24% return so there is no requirement at this stage. We do not feel any compelling reason... for Patanjali Foods, edible oils is very critical and important segment. We would like to retain that and grow that."

Balance Sheet and Cash Flow: Damage and Repair


The One-Off Thesis and What It Means for FY24

Asthana: "I would like to summarize... one off events in a particular quarter which were unprecedented in scale and suddenness that has had an impact on the company's bottom line which we are absolutely certain that which will not repeat themselves again. Of course one cannot ever predict future as to how this will go but an event which has not occurred for 20 years or series of events happening at the same time there is no likelihood that they will recur again..."

Guidance & Commitments

CommitmentSpecificsTimeline
Edible oil margin normalizationReturn to 4% margin (2–4% typical range)Q3/Q4 FY23 onward
Edible oil volume growthMaintain 4.5 lakh tonnes/quarter; 5–7% growth on topQ3 FY23 and ongoing
Food business margin normalizationTaper from 25.9% to 15–18% run rate (effort to reach 18%)Ongoing from Q3 FY23
Food business revenue growthAcquired portion to grow 10–15% consistently; at least 15–20% YoYOngoing
Nutraceutical full-year revenue₹700–800 CrFY23
FY24 company EBITDA₹2,200–2,400 CrFY24
FY24 food profit contribution~50% of company profitsFY24
Operating cash flowPositive on full-year basisFY23
Trade receivables recoveryRecovered within the last quarter of this financial yearQ4 FY23
Quarterly volume disclosureInclude volume numbers in oil business disclosuresGoing forward

Key Metrics

MetricQ2 FY23
Revenue₹8,500 thousand Crores
EBITDA~₹205 Crores
PAT₹112 Crores
Oil and vanaspati segment revenue~₹5,900 Crores
Oil and vanaspati segment EBITDANegative ₹450 Crores, 7.63% margin
Foods business revenue~₹2,400 Crores
Foods business EBITDA₹460 Crores, 28.8% margin
Foods business overall margin25.9%
Nutraceuticals revenue₹400 Crores
Nutraceuticals EBITDA~₹140 Crores, ~35% margin
Acquired food business from PAL revenue₹1,241 Crores
Acquired food business from PAL margin25.5%
Biscuit business revenueAlmost ₹350 Crores
Biscuit business margin5.5%, typically 8–10%
Realized losses booked in edible oil during quarter₹200 Crores
Mark-to-market losses at end of September quarter₹250 Crores
Edible oil sales volume growth YoYMore than 10%
Edible oil monthly volume run rate1.5 lakh tonnes, previously 1.25–1.35 lakh tonnes
Edible oil volume target4.5 lakh tonnes per quarter, with 5–6% growth
Trade receivables as of September 30, 2022~₹2,000 Crores, up from ₹796 Crores on March 31, 2022
Oil business credit period22 to 25 days
Food business credit period1 to 1.5 months
FY24 EBITDA target₹2,200 to ₹2,400 Crores
Food business FY24 margin contribution targetAbout 50% of company profits
Nutraceuticals full-year FY23 revenue target₹700 to ₹800 Crores
New channel revenue contribution in quarterAt least ₹300 to 350 Crores
Food business revenue growth target15–20% year-on-year
Food business margin targetCloser to 18%, taken over at 15%
Edible oil normalized margin target2% to 4%, objective of 4%
Food business acquisition price₹690 Crores